<DOC>
	<DOCNO>NCT02623140</DOCNO>
	<brief_summary>The aim Danish Organization Randomized Trials Clinical Outcome ( SORT OUT ) compare safety efficacy polymer-free Biolimus-eluting BIOFREEDOM stent biodegradable-polymer Sirolimus-eluting ORSIRO stent population-based setting , use registry detection clinically driven event</brief_summary>
	<brief_title>BIOFREEDOM Stent Versus ORSIRO Stent : SORT OUT IX</brief_title>
	<detailed_description>SORT OUT IX randomize , multicenter , all-comer , two-arm , non-inferiority trial compare polymer-free Biolimus-eluting BIOFREEDOM stent biodegradable-polymer Sirolimus-eluting ORSIRO stent treat atherosclerotic coronary artery lesion . Patients enrol investigator randomly allocate treatment group diagnostic coronary angiography percutaneous coronary intervention . Block randomization centre ( permuted block random size ( 2/4/6 ) ) use assign patient 1:1 ratio receive polymer-free Biolimus-eluting BIOFREEDOM stent ( Biosensors ) biodegradable-polymer Sirolimus-eluting ORSIRO stent ( Biotronik ) . A web base Trial Partner randomization system use .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Patients age 18 year chronic stable coronary artery disease acute coronary syndrome , least one coronary artery lesion 50 % diameter stenosis , require treatment drugeluting stent . Life expectancy less one year ; allergy aspirin , clopidogrel , ticagrelor , prasugral , biolimus sirolimus ; participation another randomize trial ; inability provide write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Coronary drug elute stent</keyword>
	<keyword>Outcomes</keyword>
</DOC>